RENBP and atherosclerosis: It was known that Zhenzhu Pills might be involved in signal transduction pathways such as advanced glycation end products-receptor for advanced glycation end products (AGE-RAGE) signaling pathway (hsa04933), tumor necrosis factor (TNF) signaling pathway (hsa04668), lipid and atherosclerosis (hsa05417), IL17 signaling pathway (hsa04657), and fluid shear stress and atherosclerosis (hsa05418) in the treatment of ICH.